FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045508941> ?p ?o ?g. }

• W2045508941 endingPage "662" @default.
• W2045508941 startingPage "656" @default.
• W2045508941 abstract "Although all HIV drugs developed to date are prone to the problem of drug resistance, there is hope that second generation integrase inhibitors may prove to be relatively resilient to this problem and to retain efficacy over long periods. This review summarizes information about the integrase mutations identified to date and about why the most recently developed members of this drug class may be superior to earlier drugs. Several newly identified resistance mutations, such as G118R, R263K and S153Y, have been identified through tissue culture selection studies with second-generation integrase strand-transfer inhibitors (INSTIs). These new mutations add to our understanding of the three previously identified resistance pathways involving mutations at positions Y143, N155 and Q148. Biochemical analyses structural modeling, and deep sequencing are methods that currently help in the understanding of the mechanisms of resistance conferred by these various substitutions. Despite the fact that these new resistance mutations confer only low-level cross-resistance to second-generation drugs, the Q148 pathway with numerous secondary mutations has the potential to significantly decrease susceptibility to all members of the INSTI family of drugs. Selection of mutations in vitro with second-generation INSTIs suggests that only low level cross-resistance may exist between these new drugs and first-generation members of this class. The emergence of mutations at position Q148 should be monitored whenever possible and more data are needed to assess the long-term efficacy of second-generation INSTIs in patients who may have failed older INSTIs such as elvitegravir and raltegravir." @default.
• W2045508941 created "2016-06-24" @default.
• W2045508941 creator A5029881635 @default.
• W2045508941 creator A5042169672 @default.
• W2045508941 creator A5045766366 @default.
• W2045508941 date "2012-10-01" @default.
• W2045508941 modified "2023-10-17" @default.
• W2045508941 title "The development of novel HIV integrase inhibitors and the problem of drug resistance" @default.
• W2045508941 cites W1964048276 @default.
• W2045508941 cites W1967390610 @default.
• W2045508941 cites W1983837630 @default.
• W2045508941 cites W1983855045 @default.
• W2045508941 cites W1989218343 @default.
• W2045508941 cites W1990069515 @default.
• W2045508941 cites W1991614900 @default.
• W2045508941 cites W1994293556 @default.
• W2045508941 cites W1995147807 @default.
• W2045508941 cites W1999510588 @default.
• W2045508941 cites W2007825562 @default.
• W2045508941 cites W2008162319 @default.
• W2045508941 cites W2012527357 @default.
• W2045508941 cites W2012752176 @default.
• W2045508941 cites W2016408686 @default.
• W2045508941 cites W2025344323 @default.
• W2045508941 cites W2026059788 @default.
• W2045508941 cites W2030854058 @default.
• W2045508941 cites W2041921162 @default.
• W2045508941 cites W2044660041 @default.
• W2045508941 cites W2046064238 @default.
• W2045508941 cites W2050023872 @default.
• W2045508941 cites W2057925552 @default.
• W2045508941 cites W2072883794 @default.
• W2045508941 cites W2075052852 @default.
• W2045508941 cites W2078975498 @default.
• W2045508941 cites W2081071457 @default.
• W2045508941 cites W2082523699 @default.
• W2045508941 cites W2085706522 @default.
• W2045508941 cites W2087144560 @default.
• W2045508941 cites W2092746828 @default.
• W2045508941 cites W2098185748 @default.
• W2045508941 cites W2098990854 @default.
• W2045508941 cites W2104122452 @default.
• W2045508941 cites W2112713806 @default.
• W2045508941 cites W2117072114 @default.
• W2045508941 cites W2117959947 @default.
• W2045508941 cites W2121720236 @default.
• W2045508941 cites W2124631799 @default.
• W2045508941 cites W2126018286 @default.
• W2045508941 cites W2133024144 @default.
• W2045508941 cites W2133594819 @default.
• W2045508941 cites W2135417699 @default.
• W2045508941 cites W2139876724 @default.
• W2045508941 cites W2140123055 @default.
• W2045508941 cites W2142492769 @default.
• W2045508941 cites W2144255757 @default.
• W2045508941 cites W2148026374 @default.
• W2045508941 cites W2148544227 @default.
• W2045508941 cites W2149150781 @default.
• W2045508941 cites W2150504993 @default.
• W2045508941 cites W2152880150 @default.
• W2045508941 cites W2154190260 @default.
• W2045508941 cites W2154498922 @default.
• W2045508941 cites W2155792409 @default.
• W2045508941 cites W2165004541 @default.
• W2045508941 cites W2169790816 @default.
• W2045508941 cites W2171086149 @default.
• W2045508941 cites W2171711893 @default.
• W2045508941 cites W2404779005 @default.
• W2045508941 doi "https://doi.org/10.1016/j.coviro.2012.08.007" @default.
• W2045508941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22989757" @default.
• W2045508941 hasPublicationYear "2012" @default.
• W2045508941 type Work @default.
• W2045508941 sameAs 2045508941 @default.
• W2045508941 citedByCount "56" @default.
• W2045508941 countsByYear W20455089412013 @default.
• W2045508941 countsByYear W20455089412014 @default.
• W2045508941 countsByYear W20455089412015 @default.
• W2045508941 countsByYear W20455089412016 @default.
• W2045508941 countsByYear W20455089412017 @default.
• W2045508941 countsByYear W20455089412018 @default.
• W2045508941 countsByYear W20455089412019 @default.
• W2045508941 countsByYear W20455089412021 @default.
• W2045508941 countsByYear W20455089412022 @default.
• W2045508941 crossrefType "journal-article" @default.
• W2045508941 hasAuthorship W2045508941A5029881635 @default.
• W2045508941 hasAuthorship W2045508941A5042169672 @default.
• W2045508941 hasAuthorship W2045508941A5045766366 @default.
• W2045508941 hasConcept C104317684 @default.
• W2045508941 hasConcept C114851261 @default.
• W2045508941 hasConcept C142462285 @default.
• W2045508941 hasConcept C14430832 @default.
• W2045508941 hasConcept C2522874641 @default.
• W2045508941 hasConcept C2777068322 @default.
• W2045508941 hasConcept C2777302000 @default.
• W2045508941 hasConcept C2780404665 @default.
• W2045508941 hasConcept C2993143319 @default.
• W2045508941 hasConcept C501734568 @default.
• W2045508941 hasConcept C54355233 @default.

• next